ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $562,704 | $473,340 | $233,569 | $557,928 |
| - Cash | $59,406 | $23,384 | $66,840 | $226,006 |
| + Debt | $9,357 | $10,213 | $2,659 | $1,926 |
| Enterprise Value | $512,655 | $460,169 | $169,388 | $333,848 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,107 | -$1,032 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$126,740 | -$109,748 | -$85,801 | -$77,974 |
| % Margin | – | – | – | – |
| Net Income | -$127,847 | -$100,697 | -$89,122 | -$78,715 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.83 | -1.96 | -2.25 | -2.07 |
| % Growth | 6.6% | 12.9% | -8.7% | – |
| Operating Cash Flow | -$112,662 | -$85,688 | -$75,143 | -$59,541 |
| Capital Expenditures | -$1,188 | -$849 | -$2,078 | -$939 |
| Free Cash Flow | -$113,850 | -$86,537 | -$77,221 | -$60,480 |